49
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy

, , , , , , , , & show all
Pages 2305-2313 | Published online: 26 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shandong Tao, Chunling Wang, Yue Chen, Yuan Deng, Lixiao Song, Yuyue Shi, Lanlan Ling, Banghe Ding, Zhengmei He & Liang Yu. (2019) Long-term effect of all-trans retinoic acid and arsenic trioxide sequential maintenance in patients with acute promyelocytic leukemia. Leukemia & Lymphoma 60:3, pages 711-719.
Read now

Articles from other publishers (10)

Sunil Girish Iyer, Laila Elias, Michele Stanchina & Justin Watts. (2023) The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions. Frontiers in Oncology 12.
Crossref
Vladimir Ivanov, Su-Peng Yeh, Jiri Mayer, Lalit Saini, Ali Unal, Michael Boyiadzis, David M Hoffman, Kingston Kang, Sadiya N Addo, Wellington L Mendes & Amir T Fathi. (2022) Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia. Future Oncology 18:26, pages 2879-2889.
Crossref
Patrick K. Reville & Tapan M. Kadia. (2021) Maintenance Therapy in AML. Frontiers in Oncology 10.
Crossref
Shiwei Yang, Rongjun Ma, Xiaoli Yuan, Li Jiang, Jie Shi, Jing Yang, Pingchong Lei, Yuzhu Zang, Xiangli Chen, Yin Zhang, Zhongwen Liu, Jianmin Guo, Lin Zhang, Xiaojian Zhu & Zunmin Zhu. (2020) Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 20:7, pages e382-e391.
Crossref
Matteo Molica, Massimo Breccia, Roberto Foa, Elias Jabbour & Tapan M. Kadia. (2019) Maintenance therapy in AML: The past, the present and the future. American Journal of Hematology 94:11, pages 1254-1265.
Crossref
Ryan W. Holloway, Margaret L. Thomas, Alejandro M. Cohen, Alamelu G. Bharadwaj, Mushfiqur Rahman, Paola Marcato, Paola A. Marignani & David M. Waisman. (2018) Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)☆. Cell Death & Disease 9:9.
Crossref
Akinobu Ota, Md Wahiduzzaman & Yoshitaka Hosokawa. 2018. Current Understanding of Apoptosis - Programmed Cell Death. Current Understanding of Apoptosis - Programmed Cell Death.
Yue Han, Ai-Hua Zhang, Ying-Zhi Zhang, Hui Sun, Xiang-Cai Meng & Xi-Jun Wang. (2018) Chemical metabolomics for investigating the protective effectiveness of Acanthopanax senticosus Harms leaf against acute promyelocytic leukemia . RSC Advances 8:22, pages 11983-11990.
Crossref
Shibing Chen, Juan Yu, Xin Lv & Lijuan Zhang. (2017) HOXA9 is critical in the proliferation, differentiation, and malignancy of leukaemia cells both in vitro and in vivo. Cell Biochemistry and Function 35:7, pages 433-440.
Crossref
. (2017) Multiple drugs. Reactions Weekly 1658:1, pages 330-330.
Crossref